Merck & Co. is building a new biomanufacturing facility in Dublin, Ireland. 

The facility will be constructed on an existing property owned by Merck & Co., the site of its former facility in Swords, County Dublin. With the facility, the company expects to create up to 350 new jobs.

This follows an announcement by Merck & Co. in May 2017 that the company planned to create 330 new jobs and invest EUR 280 million ($350 million) over the next several years at two of its Irish manufacturing sites, Brinny, County Cork and Carlow, Ireland.

The company’s Brinny, County Cork site is an integrated site for the development, testing, and manufacturing of biologics, specializing in the fermentation, purification and sterile filling of biologics products. Merck & Co.’s site in Carlow is the company’s first stand-alone vaccine and biologics manufacturing facility outside the US.

Source: IDA Ireland